Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Estriol ELISA Kit

Reactivity: Hormone Competition ELISA
Catalog No. ABIN930557
  • Target See all Estriol ELISA Kits
    Estriol
    Reactivity
    Hormone
    Method Type
    Competition ELISA
    Application
    ELISA
    Characteristics
    ELISA kit for the detection of Estriol free in the research laboratory
    Alternative Names: Estriol ELISA kit
    Purification
    Antiserum
    Top Product
    Discover our top product Estriol ELISA Kit
  • Application Notes
    Optimal conditions to be determined by end user
    Assay Procedure

    This unconjugated Estriol ELISA Kit is a solid phase enzymelinked immunosorbent assay (ELISA), based on the principle of competitive binding. The microtiter wells are coated with a polyclonal [rabbit] antibody directed towards an antigenic site on the Estriol molecule. Endogenous Estriol of a patient sample competes with an Estriolhorseradish peroxidase conjugate for binding to the coated antibody. After incubation the unbound conjugate is washed off. The amount of bound peroxidase conjugate is inversely proportional to the concentration of Estriol in the sample. After addition of the substrate solution, the intensity of colour developed is inversely proportional to the concentration of Estriol in the patient sample.

    Restrictions
    For Research Use only
  • Storage
    4 °C
    Storage Comment
    Store at 2-8 °C.
  • Target See all Estriol ELISA Kits
    Estriol
    Abstract
    Estriol Products
    Target Type
    Hormone
    Background
    Estriol (E3) is the major estrogen formed by the fetoplacental unit during pregnancy. Unconjugated E3 passes through the placenta into the maternal circulation, where it is rapidly converted into glucuronide and sulfate derivatives to facilitate its excretion. The halflife of estriol in the maternal bloodstream is only 20-30 minutes. Its measurement, therefore offers a convenient and quick evaluation of current fetal status. Plasma estriol levels increase steadily throughout pregnancy and most rapidly during the third trimester (28-40 weeks). A sudden decrease in fetoplacental E3 production will result in a rapid fall in unconjugated E3 in the maternal serum. There are several potential advantages to measuring unconjugated E3 rather than total serum or urinary E3. Unconjugated estriol levels are free from effects related to maternal renal or hepatic disease, and are not altered by the administration of certain antibiotics. Unconjugated E3 more accurately reflects fetal outcome in diabetic pregnancies and since no hydrolysis of unconjugated E3 is required, a more rapid tumaround for the test result is possible.
    Synonyms: Estriol ELISA kit.
You are here:
Support